Explore funding opportunities dedicated to driving healthcare innovation. Whether you're developing ground-breaking solutions or leading collaborative research projects, our Funding Directory highlights valuable support to help bring your ideas to life.
The list below provides an overview of current funding opportunities and is updated regularly. Please note, this is not an exhaustive directory and only highlights a selection of available calls.
Our funding team has access to a comprehensive global database of funding calls and initiatives. If you're seeking a more extensive and tailored search to find the right opportunities for your innovation, we’re here to help.
If you’re looking for guidance on the types of funding you can access, innovation stages, or how to navigate the wider research landscape, we’ve created a dedicated set of resources to support you. On our Funding Support page, you can download toolkits that explain key terminology, study designs, and provide practical advice to strengthen your proposal. We also maintain an internal library of templates, such as Gantt charts, logic models, and risk registers, commonly required by funders.
Submit an enquiry if you're looking for guidance, bid review and editing, or help finding the perfect opportunity for your project.
Funding for independent scientific research in type 2 inflammation and its associated diseases, including atopic dermatitis, asthma and chronic rhinosinusitis with nasal polyps.
Award for internationally acclaimed researchers in cancer care. The prize is awarded every two years to recognise outstanding contributions to translational cancer research and patient care.
Grants for researchers in Denmark to partner with international researchers to conduct exploratory research projects to develop tools to combat emerging and increasing threats from infectious diseases, including pathogenic fungi, novel antimicrobial resistance (AMR) tools and harnessing innate immunity.
Funding for basic and clinical research projects aimed at advancing current knowledge of any aspect of autoimmunity in type 1 diabetes, including pathogenesis, screening and monitoring, clinical course and interventions.
Programme to support research projects relating to public health and social care in the UK that identify, evaluate and combine data from existing research studies to provide best evidence.
Grants designed to support preparatory work required to develop project proposals for the NIHR Programme Grants for Applied Research (PGfAR) scheme, or to further develop an existing or ongoing PGfAR-funded programme of research.
The Haleon Awards, together with the Oral & Dental Research Trust (ODRT), are small grant awards available to early career researchers to help fund research programmes into the fundamental mechanisms, prevention and management of plaque-related oral disease or tooth wear.
Fellowships for postdoctoral health professionals in the UK to undertake independent research to develop an independent career in academic stroke research.
The aim of this competition is to support the development and use of digital, automated and robotic technologies to improve the speed and efficiency of pharmaceutical process development and manufacturing. These technologies will contribute to the vision of the Labs of the Future for medicines development and manufacturing.
Funding to support collaborative research and development of medical devices, in vitro diagnostic devices and high-impact patient-focused digital health technologies for use in the NHS or social care system in the UK.
Grants are available to support businesses investing in life sciences manufacturing projects in the UK which can drive growth and build resilience for future health emergencies.
Fellowship funding to enable researchers to visit centres for clinical or diagnostic virology in Europe, with the aim of furthering knowledge in clinical or diagnostic virology.
The Foundation's Conference Awards for Ageing Research support allied health professionals, nurses and pharmacists who are actively involved in ageing-related research and wish to disseminate their findings at national or international conferences. The aim is to support early career researchers who do not have access to conference funds through existing grants or fellowships.
Funding over a maximum of two years for innovative research examining the impact of environmental pollution and climate change on lung cancer risk, diagnosis and treatment, with the additional objective of delivering outcomes to inform innovative strategies to mitigate the effects of environmental pollution on lung cancer risk.
Funding over a maximum of five years to support biological, psychological and social research to improve the early detection, diagnosis and prevention of arthritis and the development of reliable and effective personalised treatments and interventions.
Accepting applications that will advance translational research to better understand the emergence, trajectory and outcomes of schizophrenia and related psychotic disorders in mid- to late-life, and to identify targets for future development of prevention and treatment interventions.
The NIAAA invites applications for research projects focused on closing the treatment gap for alcohol use disorder (AUD). Priorities include improving access, appeal, and implementation of treatments, analysing cost and insurance systems, and addressing health disparities. Projects may span multiple disciplines, with up to five years’ funding.
The National Cancer Institute (NCI) intends to stimulate research in discovery and development of novel, small molecules for cancer. Molecules discovered may be used to probe cancer biology, to validate cancer targets or as the basis for optimised drugs.
Funding for outstanding researchers with innovative ideas to enable them to achieve a breakthrough that will have a major impact on patients in any disease area.
Rosetrees has launched the New Exceptional Transformational Award (NEXT) to replace the discontinued Interdisciplinary Award. The scheme will fund a single exceptional researcher with high risk, high reward ideas to enable them to achieve a breakthrough that will have a major impact on patients in their chosen disease area.
This funding opportunity supports developing data and metadata standards for wearable technology to improve mental health research. Recipients will collaborate with manufacturers, researchers, and ethics experts to enable data integration, like DICOM for imaging. Funding depends on NIH budgets; projects may last up to four years with no budget cap.
Fellowship scheme for early career researchers and innovators looking to establish or transition to independence, or to develop their own ambitious plans within a commercial setting. Fellowships are available in any field of study covered by UK Research and Innovation.
Funding for UK-based universities and providers of care services for high-quality social care research that generates evidence to improve, expand and strengthen the way adult social care in the UK is delivered for users of care services, carers and the public.
Funding over a maximum of five years for translational research by UK research teams - including joint projects with teams in the US and Canada - based on developing a biological and mechanistic understanding of cancer aetiology, genesis and risk to develop precision prevention interventions.
Funding is available for UK-based researchers to develop and implement applied health and social care solutions that help people with arthritis live well and improve long-term outcomes.
Grants to support early career researchers in the UK undertaking translational or proof of concept research in any area of gastroenterology (including pancreatology and hepatology).
Funding available to UK organisations and educational establishments for the funding of capital infrastructure in the fields of science and medicine, health, education and the arts and humanities.
The Sarcoma UK grants programme funds scientific and medical research to investigate the mechanisms of all forms of bone and soft tissue cancers and develop more effective diagnostics and treatments. Its Research Strategy for 2021-2026 aims to ensure everyone affected by sarcoma receives the best treatment, care, information and support available and focuses on researching causes, diagnostics and treatment to improve quality of life, balanced across multiple sarcoma subtypes.
The Medical Research Foundation Antimicrobial Resistance Research funding call provides targeted grants to support innovative projects addressing drug-resistant infections. It typically offers funding for early- to mid-career researchers, covering research costs and sometimes salary support, with an emphasis on high-risk, high-reward ideas, interdisciplinary approaches, and building research capacity in underfunded areas of antimicrobial resistance.
The Research for Patient Benefit (RfPB) programme is launching a commissioned call that expressly invites applications that focus on the health research priorities identified by the Department of Health and Social Care (DHSC) known as areas of research interest (ARIs).
Funding is available for mechanistically informed trials of interventions for anxiety and depression in young people aged 10-18 years carried out in the UK and/or Africa.
The NIHR is seeking to fund a single modelling study to determine the clinical and cost‑effectiveness of different transabdominal ultrasound surveillance strategies (including no surveillance) for adults with gallbladder polyps. The study should use robust quantitative modelling and health economic analysis, drawing on existing datasets and potentially new prospective or qualitative data, to compare outcomes such as life expectancy, cancer detection, resource use, and acceptability to patients and staff.
The NIHR is seeking studies that evaluate clinically and cost‑effective early intervention programmes for infants under 12 months who have an increased chance of neurodisability. Funded trials should assess multi‑domain child development outcomes, alongside impacts on parent/carer wellbeing and family functioning, using a randomised controlled design with at least 12 months’ follow‑up.
The NIHR is seeking to fund a single large UK trial evaluating the effectiveness and cost‑effectiveness of Palliative Care Needs Rounds - specialist‑led, structured palliative care support - in residential care homes for older people. The study should use a cluster randomised design with an internal pilot and assess outcomes such as residents’ quality of death, staff and family confidence, hospital admission patterns, and economic impacts on the NHS and care homes.
The NIHR is seeking to fund a single randomised controlled trial evaluating the clinical and cost‑effectiveness of pharmacological treatment - with and without continued cognitive behavioural therapy - for adults receiving NHS gambling treatment services who have not responded adequately to CBT alone.
The NIHR is seeking to fund a single large UK trial evaluating the effectiveness and cost‑effectiveness of Palliative Care Needs Rounds - specialist‑led, structured palliative care support - in residential care homes for older people. The study should use a cluster randomised design with an internal pilot and assess outcomes such as residents’ quality of death, staff and family confidence, hospital admission patterns, and economic impacts on the NHS and care homes.
Funding available to support early career researchers working in any discipline to prepare them to lead their own independent research programme and thereby benefit human life, health and wellbeing.
Entry Level Scholarships to support predoctoral researchers in undertaking early stage research projects focused on the prevention of cancer of the cervix and lower genital tract.
Funding over a maximum of 18 months to support the development of protocols, interventions, novel diagnostics and other research activity that supports the integration of mental health into paediatric rheumatology care for families with Juvenile Myositis (JM).
Funding over a maximum of 18 months to support the development of protocols, interventions, novel diagnostics and other research activity that supports the integration of mental health into paediatric rheumatology care for families with Juvenile Myositis (JM).
The funding bid supports research evaluating community-level initiatives that prevent or reduce loneliness in the UK. It seeks to assess the health and health inequality impacts of interventions—including community assets, place-based approaches, social skills programs, and virtual communities—focusing specifically on loneliness rather than social isolation, to inform effective population-level strategies.
NIHR aims to fund research on how best to improve communication around women’s health across the life course, particularly in underserved or marginalised communities. Of particular interest are interventions that are delivered outside of clinical settings and aim to promote health and wellbeing at the population level, especially through community, voluntary sector, educational or digital settings.
The NIHR HTA seeks applications for a trial on alternate day caplacizumab treatment for immune thrombotic thrombocytopenic purpura (iTTP). The study will assess if alternate day treatment is as effective as daily dosing, reducing risks and costs. It follows a two-stage application process: outline proposal and full application.
The Wellcome Career Development Awards fund mid-career researchers to lead ambitious, independent programmes that advance understanding of human health. Awards typically last up to eight years, covering salary and research costs. Applicants must show leadership potential, innovation, and capacity to become internationally recognised research leaders.
Funding available to support academic researchers using AstraZeneca's compound library and screening robots to discover potential research starting points for small molecule medicinal drugs.
The Vanguard Initiative has launched an interregional scheme supporting Welsh organisations to collaborate on innovative projects with partners across Europe. The VInnovate Call will provide financial support (grants) to stakeholders (SMEs cooperating with other companies and/or research/technology centres or universities) located in the VInnovate participating regions. The Call will support activities at TRL6, TRL7 and/or TRL8; meaning that VInnovate will support post-prototyping activities.
The overall goal of this topic is to advance the understanding of older cancer patients' care needs, and develop innovative, age-sensitive care approaches and tools to boost overall quality of life.
This call funds multidisciplinary research to improve quality of life for cancer patients aged 65+, focusing on understanding care needs, developing age-appropriate interventions, and generating evidence for healthcare systems. Projects should deliver scalable, patient-centred solutions, including clinical studies and stakeholder collaboration, to enhance treatment, follow-up care, and overall wellbeing
This topic aims to improve palliative care for cancer patients by developing innovative, personalized, and integrated models. Focus areas include early care, AI and digital tools for communication and care predictions, and addressing workforce challenges. Proposals should test models in real-world settings, collaborate with EU4Health, and join the EU Cancer Mission’s 'Quality of Life' cluster.
This funding supports research to develop and validate microbiome-based tools for early cancer prediction and prevention. It finances longitudinal data collection, AI-driven risk modelling, comparison with liquid biopsy tests, validation in independent cohorts, and stakeholder and citizen engagement to advance personalised, minimally invasive early detection aligned with the EU Cancer Mission.
The EU Cancer Mission seeks to develop a digital platform for mental health support targeting AYA cancer patients (ages 15-39). It should integrate with EU-CIP, offer personalized tools, and be multi-device and multilingual. Collaboration with end-users and experts is essential for testing, validation, and aligning with EU Health Data Space guidelines.
The BAPRAS Pump Priming Fund offers a single grant each year to support pump priming clinical trial projects in the field of plastic surgery. The aim of the award is to support early feasibility work for a proposed clinical trial in support of a subsequent application for funding from the NIHR or other large funding body.
The purpose of this Notice of Funding Opportunity (NOFO) is to support applications for novel theory and methods development that enable better understanding of how genetic and non-genetic factors contribute to complex trait variation across individuals, families and populations.
The Medical Research Council (MRC) provides experimental medicine grants to support academically-led experimental medicine projects that address gaps in current understanding of the causes, progression and treatment of human disease through experimental intervention, or challenge, in humans.
Sigma Theta Tau International Honour Society of Nursing - known as Sigma - is an international representative body for nurses and nursing. Its mission is to advance world health and celebrate nursing excellence in scholarship, leadership and service, and to respond to trends and issues in nursing and healthcare. In collaboration with the Rosemary Berkel Crisp Foundation, Sigma offers a Research Grant is to support nursing research in the critical areas of women's health, oncology and paediatrics.
Funding to conduct rapid baseline data collection, as well as other feasibility work, prior to intervention implementation, for time-limited opportunities such as a natural experiment or similar evaluations of a new public health intervention.
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) is inviting research projects that implement early phase (Phase 0, I and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of NCI's Division of Cancer Treatment and Diagnosis (DCTD) and Office of HIV and AIDS Malignancies (OHAM). The proposed project must involve at least one clinical trial related to the scientific interests of one or more of the following research programs: Cancer Therapy Evaluation Program, Cancer Imaging Program, Cancer Diagnosis Program, Radiation Research Program, Complementary and Alternative Medicine Program, and/or the HIV and AIDS Malignancies Research Programs.
The National Cancer Institute (NCI) invites applications for investigator-initiated clinical trials aimed at reducing cancer burden through early detection, prevention, healthcare delivery, quality of life, or survivorship. The trials should improve clinical practice or public health. Budgets are flexible, and the maximum project duration is five years.
Funding to establish challenge-led MRC Centres of Research Excellence (CoRE) to tackle complex and interdisciplinary health challenges and train the next generation of researchers and technologists.
Funding to establish challenge-led MRC Centres of Research Excellence (CoRE) to tackle complex and interdisciplinary health challenges and train the next generation of researchers and technologists.
This funding supports implementation research to prevent, detect and manage chronic non-communicable diseases from early childhood to young adulthood. It finances evidence-based interventions in LMICs and underserved populations, addressing social determinants of health, equitable delivery, capacity building, and policy-relevant solutions to improve lifelong non-communicable disease outcomes.
Provision of a clinical and academic training environment for a doctor or dentist in the early stages of specialty training to prepare an application for a Training Fellowship leading to a PhD (or equivalent) or, if applicable, a postdoctoral fellowship.
The AI Continent Action Plan identifies the health sector, encompassing life sciences, medical devices and healthcare delivery, as one of the key strategic sectors. The action will contribute to making European life sciences and healthcare more impactful and productive by fostering the full integration of advanced AI in the health sector and biomedical research, along the objectives of the AI in Science strategy and Apply AI strategy.
This NOFO encourages research to improve mental health services for individuals with or at risk for mental illness. It invites non-clinical R01-level projects aligned with NIMH strategic priorities, focusing on factors affecting access, quality, scalability, and outcomes. The maximum project period is five years, with triannual submission deadlines.
Applications for innovative research projects to test strategies to increase the reach, efficiency, effectiveness and quality of digital mental health interventions that may impact mental health outcomes, including suicide behaviours and serious mental illness.
This Notice of Funding Opportunity (NOFO) encourages grant applications from investigators interested in conducting basic research studies into the biological/genetic causes and mechanisms of cancer health disparities. The overall goal of this NOFO is to identify cancer risks and risk reduction strategies, to identify factors that cause cancer in humans, and to discover and develop mechanisms for cancer prevention and preventive interventions in humans.
The purpose of this Notice of Funding Opportunity (NOFO) is to encourage applications seeking to develop the next generation of brain stimulation devices for treating mental health disorders.
This funding opportunity supports clinical trials of orphan products (phases 1–3) for rare diseases with unmet medical needs. It aims to evaluate safety and/or efficacy to support new indications or labeling changes, ultimately increasing approved treatments and advancing innovative, collaborative approaches in rare disease drug development.
Capital grants for UK-registered private sector life sciences companies for large-scale R&D projects that are primarily capital investments and dependent on the grant to proceed.
